Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Fetching the latest fund profile, holdings, and market data.
New York Stock Exchange Arca · Leveraged/Inverse
$87.53
+$13.22 · +17.79%
· Aug 21, 4:00 PM ET
$87.71
+$0.18 · +0.21%
· Aug 24, 4:07 AM ET
$87.53
Previous close+$13.22 · +17.79%
· Aug 21, 4:00 PM ET
$87.71
+$0.18 · +0.21%
· Aug 24, 4:07 AM ET
$87.60
+$13.29 · +17.88%
Regular session · ET · Market data may be delayed.
The MRNX fund is designed to generate returns by taking a leveraged, bullish stance on the daily share price movements of Moderna, Inc. (MRNA). It achieves this primarily through the use of swap agreements and short-term listed call options. Its objective is to deliver a daily return equivalent to 200% (twice) the daily percentage change in MRNA's stock price, which it maintains through daily rebalancing. However, holding the fund for periods exceeding a single day may lead to actual returns that deviate significantly from this 2x daily target, influenced by factors like market volatility, compounding, and rebalancing impacts. For collateral supporting its derivative contracts, MRNX may also invest in stable assets such as U.S. government securities, money market funds, short-term bond exchange-traded funds (ETFs), and investment-grade corporate debt.
Fund assets
26.3M USD
Expense ratio
1.31%
NAV
$87.68
Average volume
107.27K
Volume
1.89M
Day range
$74.00 – $103.86
52-week range
$14.95 – $143.84
Previous close
$74.31
Price change
1 day
+17.79%
1 month
+267.46%
3 months
+320.62%
Year to date
+329.49%
1 year
+329.49%
3 years
+329.49%
5 years
+329.49%
Price changes exclude distributions, fees, taxes, and investor-specific cash flows.
Portfolio
Holdings data updated Aug 24, 2026.
Latest coverage
No ETF news is currently available.
More funds
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.
